Recursion Pharmaceuticals raises $121m to map how disease affects cells
Recursion Pharmaceuticals raises $121m to map how disease affects cells | Financial Times Recursion Pharmaceuticals, which uses artificial intelligence to try to discover drugs, has raised $121m in a round led by Baillie Gifford. The Salt Lake City-based company is the latest drug discovery start-up to raise funds in the past year, as investors flock […]